Anoat is a seed startup based in France. 1 investor tracked.
Anoat is a company headquartered in France. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Anoat Therapeutics is a drug development and preclinical-stage company specializing in research and insights into rare diseases and anti-sense oligonucleotide (ASO) drug development, particularly focusing on cystic fibrosis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.